254 related articles for article (PubMed ID: 19717648)
21. IRF4 negatively regulates proliferation of germinal center B cell-derived Burkitt's lymphoma cell lines and induces differentiation toward plasma cells.
Teng Y; Takahashi Y; Yamada M; Kurosu T; Koyama T; Miura O; Miki T
Eur J Cell Biol; 2007 Oct; 86(10):581-9. PubMed ID: 17651861
[TBL] [Abstract][Full Text] [Related]
22. Histone demethylase KDM5A is transactivated by the transcription factor C/EBPβ and promotes preadipocyte differentiation by inhibiting Wnt/β-catenin signaling.
Guo L; Guo YY; Li BY; Peng WQ; Tang QQ
J Biol Chem; 2019 Jun; 294(24):9642-9654. PubMed ID: 31061100
[TBL] [Abstract][Full Text] [Related]
23. C/EBPβ regulates P2X7 receptor expression in response to glucose challenge in intestinal epithelial cells.
Bilodeau MS; Arguin G; Gendron FP
Biochem Cell Biol; 2015 Feb; 93(1):38-46. PubMed ID: 25403356
[TBL] [Abstract][Full Text] [Related]
24. Sequential gene promoter interactions by C/EBPbeta, C/EBPalpha, and PPARgamma during adipogenesis.
Tang QQ; Zhang JW; Daniel Lane M
Biochem Biophys Res Commun; 2004 May; 318(1):213-8. PubMed ID: 15110775
[TBL] [Abstract][Full Text] [Related]
25. Epidermal growth factor down-regulates the expression of human hepatic stimulator substance via CCAAT/enhancer-binding protein β in HepG2 cells.
Dong LY; Sun G; Jiang L; Shao L; Hu Y; Jiang Y; Wang Y; An W
Biochem J; 2010 Oct; 431(2):277-87. PubMed ID: 20690902
[TBL] [Abstract][Full Text] [Related]
26. CCAAT/enhancer binding protein β negatively regulates progesterone receptor expression in human glioblastoma cells.
Hansberg-Pastor V; González-Arenas A; Camacho-Arroyo I
Mol Cell Endocrinol; 2017 Jan; 439():317-327. PubMed ID: 27663075
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of C/EBPbeta represses human papillomavirus type 18 upstream regulatory region activity in HeLa cells by interfering with the binding of TATA-binding protein.
Bauknecht T; Shi Y
J Virol; 1998 Mar; 72(3):2113-24. PubMed ID: 9499067
[TBL] [Abstract][Full Text] [Related]
28. High XBP1 expression is a marker of better outcome in multiple myeloma patients treated with bortezomib.
Gambella M; Rocci A; Passera R; Gay F; Omedè P; Crippa C; Corradini P; Romano A; Rossi D; Ladetto M; Boccadoro M; Palumbo A
Haematologica; 2014 Feb; 99(2):e14-6. PubMed ID: 24497562
[No Abstract] [Full Text] [Related]
29. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
30. C/EBPβ expression in ALK-positive anaplastic large cell lymphomas is required for cell proliferation and is induced by the STAT3 signaling pathway.
Anastasov N; Bonzheim I; Rudelius M; Klier M; Dau T; Angermeier D; Duyster J; Pittaluga S; Fend F; Raffeld M; Quintanilla-Martinez L
Haematologica; 2010 May; 95(5):760-7. PubMed ID: 20015877
[TBL] [Abstract][Full Text] [Related]
31. Gm40600 suppressed SP 2/0 isograft tumor by reducing Blimp1 and Xbp1 proteins.
Fang Y; Xu R; Zhai B; Hou C; Ma N; Wang L; Han G; Jiang Z; Wang R
BMC Cancer; 2019 Jul; 19(1):700. PubMed ID: 31311517
[TBL] [Abstract][Full Text] [Related]
32. MUM1/IRF4 expression as a frequent event in mature lymphoid malignancies.
Tsuboi K; Iida S; Inagaki H; Kato M; Hayami Y; Hanamura I; Miura K; Harada S; Kikuchi M; Komatsu H; Banno S; Wakita A; Nakamura S; Eimoto T; Ueda R
Leukemia; 2000 Mar; 14(3):449-56. PubMed ID: 10720141
[TBL] [Abstract][Full Text] [Related]
33. NPM-ALK-dependent expression of the transcription factor CCAAT/enhancer binding protein beta in ALK-positive anaplastic large cell lymphoma.
Quintanilla-Martinez L; Pittaluga S; Miething C; Klier M; Rudelius M; Davies-Hill T; Anastasov N; Martinez A; Vivero A; Duyster J; Jaffe ES; Fend F; Raffeld M
Blood; 2006 Sep; 108(6):2029-36. PubMed ID: 16709933
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of collagen gene expression by interferon-gamma: novel role of the CCAAT/enhancer binding protein beta (C/EBPbeta).
Ghosh AK; Bhattacharyya S; Mori Y; Varga J
J Cell Physiol; 2006 Apr; 207(1):251-60. PubMed ID: 16331681
[TBL] [Abstract][Full Text] [Related]
35. Role of hepatitis B virus X repression of C/EBPbeta activity in the down-regulation of glutathione S-transferase A2 gene: implications in other phase II detoxifying enzyme expression.
Cho IJ; Ki SH; Brooks C; Kim SG
Xenobiotica; 2009 Feb; 39(2):182-92. PubMed ID: 19255944
[TBL] [Abstract][Full Text] [Related]
36. Targeting positive regulatory domain I-binding factor 1 and X box-binding protein 1 transcription factors by multiple myeloma-reactive CTL.
Lotz C; Mutallib SA; Oehlrich N; Liewer U; Ferreira EA; Moos M; Hundemer M; Schneider S; Strand S; Huber C; Goldschmidt H; Theobald M
J Immunol; 2005 Jul; 175(2):1301-9. PubMed ID: 16002735
[TBL] [Abstract][Full Text] [Related]
37. Differential expression and distinct functions of IFN regulatory factor 4 and IFN consensus sequence binding protein in macrophages.
Marecki S; Atchison ML; Fenton MJ
J Immunol; 1999 Sep; 163(5):2713-22. PubMed ID: 10453013
[TBL] [Abstract][Full Text] [Related]
38. PU.1 regulates positive regulatory domain I-binding factor 1/Blimp-1 transcription in lymphoma cells.
Desai S; Bolick SC; Maurin M; Wright KL
J Immunol; 2009 Nov; 183(9):5778-87. PubMed ID: 19828640
[TBL] [Abstract][Full Text] [Related]
39. Multiple myeloma cells expressing low levels of CD138 have an immature phenotype and reduced sensitivity to lenalidomide.
Kawano Y; Fujiwara S; Wada N; Izaki M; Yuki H; Okuno Y; Iyama K; Yamasaki H; Sakai A; Mitsuya H; Hata H
Int J Oncol; 2012 Sep; 41(3):876-84. PubMed ID: 22766978
[TBL] [Abstract][Full Text] [Related]
40. Activating transcription factor 6 (ATF6) negatively regulates Polo-like kinase 4 expression via recruiting C/EBPβ to the upstream-promoter during ER stress.
Shen T; Li Y; Chen Z; Liang S; Qiu Y; Zhu L; Ba G; Lu G; Qiu L
Biochim Biophys Acta Gene Regul Mech; 2020 Feb; 1863(2):194488. PubMed ID: 31926341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
